Consistent with our results, the drug screen by Dietrich et al. found high sensitivity of U-CLL to two CHEK1 inhibitors, AZD7762 and PF47736[16]. The gene discussed is CHEK1; the disease is B-cell chronic lymphocytic leukemia.